HCA Stock Recent News
HCA LATEST HEADLINES
Blue-chip stocks refer to industry-leading companies with strong financials, dominant market share, global brand recognition and a track record of steady growth over decades. These tend to be extremely stable even during volatile markets, making them appealing long-term holds.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com users have recently been watching HCA (HCA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA Healthcare (HCA) came out with quarterly earnings of $5.36 per share, beating the Zacks Consensus Estimate of $5.01 per share. This compares to earnings of $4.93 per share a year ago.
HCA Healthcare on Friday beat Wall Street estimates for quarterly profit, helped by higher patient admissions due to demand for healthcare services.
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.